Ibibull IV Infusion contains Paracetamol at a concentration of 1000 mg per 100 ml and is indicated for the management of mild to moderate pain and fever where oral administration is not feasible or contraindicated. Paracetamol, a widely used analgesic and antipyretic agent, exerts its effect primarily through central inhibition of prostaglandin synthesis, resulting in pain relief and temperature reduction. Ibibull IV Infusion is particularly useful in postoperative pain management, febrile conditions, and in patients who require rapid onset of action or cannot tolerate oral formulations. The intravenous route ensures prompt bioavailability, making it suitable for hospital settings and acute care. Dosage should be carefully calculated based on patient weight, age, and clinical condition, with careful monitoring to avoid overdose, as excessive paracetamol intake can lead to hepatotoxicity. It is contraindicated in patients with known hypersensitivity to paracetamol or any excipients in the formulation. Caution is advised in patients with liver impairment, chronic alcoholism, or concurrent use of other hepatotoxic drugs. Adverse effects are rare but may include hypersensitivity reactions. Ibibull IV Infusion should be administered under medical supervision with adherence to recommended dosing guidelines to ensure safety and efficacy.